IU
Innovate UKAccelerated Cancer Diagnosis Innovation
Fully FundedLondon, United Kingdomphd· Up to £25.4M total fund.
Project Overview
£25.4M for clinical validation and evaluation of early cancer diagnostic technologies. UK registered businesses.
Opportunity Overview
Innovate UK, for the OLS Cancer Healthcare Goals programme, invests up to £25.4M to support clinical validation and evaluation of early cancer diagnostic technologies. Funds the expensive middle stage of medtech translation: clinical validation studies, health-economic evaluation, and regulatory evidence generation.
Strategic Context
Part of UK Life Sciences Vision to improve early cancer diagnosis. Diagnostics (imaging AI, liquid biopsy, point-of-care tests, multi-cancer early detection) are highest-leverage interventions.
Eligibility
UK registered businesses developing diagnostic technologies, typically with NHS clinical partners.
Application
Via Innovation Funding Service by 28 October 2026, 11:00am UK time.
Official Link
https://apply-for-innovation-funding.service.gov.uk
Innovate UK, for the OLS Cancer Healthcare Goals programme, invests up to £25.4M to support clinical validation and evaluation of early cancer diagnostic technologies. Funds the expensive middle stage of medtech translation: clinical validation studies, health-economic evaluation, and regulatory evidence generation.
Strategic Context
Part of UK Life Sciences Vision to improve early cancer diagnosis. Diagnostics (imaging AI, liquid biopsy, point-of-care tests, multi-cancer early detection) are highest-leverage interventions.
Eligibility
UK registered businesses developing diagnostic technologies, typically with NHS clinical partners.
Application
Via Innovation Funding Service by 28 October 2026, 11:00am UK time.
Official Link
https://apply-for-innovation-funding.service.gov.uk
Closes in 47 daysApply on official site ↗